Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
Provided By GlobeNewswire
Last update: May 1, 2024
OXFORD, United Kingdom, May 01, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer, today announced the appointment of Leon Hooftman, M.D., as Chief Medical Officer (CMO).
NASDAQ:BRNS (12/19/2025, 8:00:02 PM)
0.739
+0.01 (+1.04%)
Find more stocks in the Stock Screener
